InvestorsHub Logo
Followers 42
Posts 5751
Boards Moderated 0
Alias Born 04/12/2021

Re: None

Sunday, 10/17/2021 4:40:48 PM

Sunday, October 17, 2021 4:40:48 PM

Post# of 30
2022 stock, no revenue this year as per company statements imo :

“6:16a ET 8/10/2021 - Benzinga
Nautilus Biotechnology Q2 EPS $(0.19) Misses $(0.09) Estimate

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.09) by 111.11 percent.

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”

my posts are always theory and not financial advice

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NAUT News